Potential Role for Vaccines, Checkpoint Inhibitors in Chemoprevention of Lynch Syndrome
Researchers from MD Anderson say their study results " open the field of immunoprevention in LS to checkpoint inhibitors as an immune interception strategy. "
Source: CancerNetwork - Category: Cancer & Oncology Authors: Leah Lawrence Tags: Colorectal Cancer Gastrointestinal Cancer News Source Type: news
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Colorectal Cancer | Gastroenterology | HNPCC | Legislation | Lynch Syndrome | Study | Vaccines